CSL (OTCMKTS:CSLLY) Sets New 1-Year Low – Time to Sell?

CSL Limited (OTCMKTS:CSLLY) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $75.70 and last traded at $79.07, with a volume of 116648 shares. The stock had previously closed at $78.95.

Analyst Ratings Changes

Separately, The Goldman Sachs Group raised CSL to a “strong-buy” rating in a research note on Thursday, January 16th.

CSL Stock Performance

The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97. The stock’s 50 day moving average price is $82.30 and its 200 day moving average price is $89.45.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.